347 related articles for article (PubMed ID: 25656495)
1. Morbidity and medicine prescriptions in a nationwide Danish population of patients diagnosed with polycystic ovary syndrome.
Glintborg D; Hass Rubin K; Nybo M; Abrahamsen B; Andersen M
Eur J Endocrinol; 2015 May; 172(5):627-38. PubMed ID: 25656495
[TBL] [Abstract][Full Text] [Related]
2. Cardiovascular disease in a nationwide population of Danish women with polycystic ovary syndrome.
Glintborg D; Rubin KH; Nybo M; Abrahamsen B; Andersen M
Cardiovasc Diabetol; 2018 Mar; 17(1):37. PubMed ID: 29519249
[TBL] [Abstract][Full Text] [Related]
3. Development and Risk Factors of Type 2 Diabetes in a Nationwide Population of Women With Polycystic Ovary Syndrome.
Rubin KH; Glintborg D; Nybo M; Abrahamsen B; Andersen M
J Clin Endocrinol Metab; 2017 Oct; 102(10):3848-3857. PubMed ID: 28938447
[TBL] [Abstract][Full Text] [Related]
4. Fracture Risk Is Decreased in Women With Polycystic Ovary Syndrome: A Register-Based and Population-Based Cohort Study.
Rubin KH; Glintborg D; Nybo M; Andersen M; Abrahamsen B
J Bone Miner Res; 2016 Apr; 31(4):709-17. PubMed ID: 26542642
[TBL] [Abstract][Full Text] [Related]
5. Socioeconomic status in Danish women with polycystic ovary syndrome: A register-based cohort study.
Rubin KH; Andersen MS; Abrahamsen B; Glintborg D
Acta Obstet Gynecol Scand; 2019 Apr; 98(4):440-450. PubMed ID: 30516823
[TBL] [Abstract][Full Text] [Related]
6. Hyperandrogenism and phenotypes of polycystic ovary syndrome are not associated with differences in obstetric outcomes.
Mumm H; Jensen DM; Sørensen JA; Andersen LL; Ravn P; Andersen M; Glintborg D
Acta Obstet Gynecol Scand; 2015 Feb; 94(2):204-11. PubMed ID: 25417943
[TBL] [Abstract][Full Text] [Related]
7. Increased risk of thyroid disease in Danish women with polycystic ovary syndrome: a cohort study.
Glintborg D; Rubin KH; Nybo M; Abrahamsen B; Andersen M
Endocr Connect; 2019 Oct; 8(10):1405-1415. PubMed ID: 31518989
[TBL] [Abstract][Full Text] [Related]
8. Anogenital distance in children born of mothers with polycystic ovary syndrome: the Odense Child Cohort.
Glintborg D; Jensen RC; Schmedes AV; Brandslund I; Kyhl HB; Jensen TK; Andersen MS
Hum Reprod; 2019 Oct; 34(10):2061-2070. PubMed ID: 31560039
[TBL] [Abstract][Full Text] [Related]
9. Apolipoprotein A-I and B levels, dyslipidemia and metabolic syndrome in south-west Chinese women with PCOS.
Zhang J; Fan P; Liu H; Bai H; Wang Y; Zhang F
Hum Reprod; 2012 Aug; 27(8):2484-93. PubMed ID: 22674204
[TBL] [Abstract][Full Text] [Related]
10. Cardiovascular disease and risk factors in PCOS women of postmenopausal age: a 21-year controlled follow-up study.
Schmidt J; Landin-Wilhelmsen K; Brännström M; Dahlgren E
J Clin Endocrinol Metab; 2011 Dec; 96(12):3794-803. PubMed ID: 21956415
[TBL] [Abstract][Full Text] [Related]
11. Birth weight and polycystic ovary syndrome in adult life: a register-based study on 523,757 Danish women born 1973-1991.
Mumm H; Kamper-Jørgensen M; Nybo Andersen AM; Glintborg D; Andersen M
Fertil Steril; 2013 Mar; 99(3):777-82. PubMed ID: 23200688
[TBL] [Abstract][Full Text] [Related]
12. Prescription of antidepressants is increased in Danish patients with polycystic ovary syndrome and is associated with hyperandrogenism. A population-based cohort study.
Altinok ML; Glintborg D; Depont Christensen R; Hallas J; Andersen M
Clin Endocrinol (Oxf); 2014 Jun; 80(6):884-9. PubMed ID: 24224860
[TBL] [Abstract][Full Text] [Related]
13. Central arterial stiffness and diastolic dysfunction are associated with insulin resistance and abdominal obesity in young women but polycystic ovary syndrome does not confer additional risk.
Rees E; Coulson R; Dunstan F; Evans WD; Blundell HL; Luzio SD; Dunseath G; Halcox JP; Fraser AG; Rees DA
Hum Reprod; 2014 Sep; 29(9):2041-9. PubMed ID: 25035436
[TBL] [Abstract][Full Text] [Related]
14. Cardiovascular risks and metabolic syndrome in Hong Kong Chinese women with polycystic ovary syndrome.
Cheung LP; Ma RC; Lam PM; Lok IH; Haines CJ; So WY; Tong PC; Cockram CS; Chow CC; Goggins WB
Hum Reprod; 2008 Jun; 23(6):1431-8. PubMed ID: 18359783
[TBL] [Abstract][Full Text] [Related]
15. Women with polycystic ovary syndrome have intrinsic insulin resistance on euglycaemic-hyperinsulaemic clamp.
Stepto NK; Cassar S; Joham AE; Hutchison SK; Harrison CL; Goldstein RF; Teede HJ
Hum Reprod; 2013 Mar; 28(3):777-84. PubMed ID: 23315061
[TBL] [Abstract][Full Text] [Related]
16. Risk of cancer among women with polycystic ovary syndrome: a Danish cohort study.
Gottschau M; Kjaer SK; Jensen A; Munk C; Mellemkjaer L
Gynecol Oncol; 2015 Jan; 136(1):99-103. PubMed ID: 25451694
[TBL] [Abstract][Full Text] [Related]
17. Epidemiology and adverse cardiovascular risk profile of diagnosed polycystic ovary syndrome.
Lo JC; Feigenbaum SL; Yang J; Pressman AR; Selby JV; Go AS
J Clin Endocrinol Metab; 2006 Apr; 91(4):1357-63. PubMed ID: 16434451
[TBL] [Abstract][Full Text] [Related]
18. A survey of the polycystic ovary syndrome in the Greek island of Lesbos: hormonal and metabolic profile.
Diamanti-Kandarakis E; Kouli CR; Bergiele AT; Filandra FA; Tsianateli TC; Spina GG; Zapanti ED; Bartzis MI
J Clin Endocrinol Metab; 1999 Nov; 84(11):4006-11. PubMed ID: 10566641
[TBL] [Abstract][Full Text] [Related]
19. Cardiovascular and metabolic profiles amongst different polycystic ovary syndrome phenotypes: who is really at risk?
Daan NM; Louwers YV; Koster MP; Eijkemans MJ; de Rijke YB; Lentjes EW; Fauser BC; Laven JS
Fertil Steril; 2014 Nov; 102(5):1444-1451.e3. PubMed ID: 25239303
[TBL] [Abstract][Full Text] [Related]
20. Increased prevalence of polycystic ovary syndrome in premenopausal women with nonalcoholic fatty liver disease.
Vassilatou E; Vassiliadi DA; Salambasis K; Lazaridou H; Koutsomitopoulos N; Kelekis N; Kassanos D; Hadjidakis D; Dimitriadis G
Eur J Endocrinol; 2015 Dec; 173(6):739-47. PubMed ID: 26340970
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
